GlaxoSmithKline Intellectual Property Development Limited
发明人:
WAN, Zehong,ZHANG, Xiaomin,WANG, Jian,SENDER, Matthew Robert,MANAS, Eric Steven,RIVERO, Raphael Anthony,PERO, Joseph E.,NEIPP, Christopher Ernst,PATEL, Vipulkumar Kantibhai
申请号：
ES15825267
公开号：
ES2747636T3
申请日:
2015.07.21
申请国别(地区):
ES
年份:
2020
代理人:
摘要：
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.
